Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Squamous Cell Carcinoma of Head and Neck 14 Oropharyngeal Neoplasms 12 Lung Neoplasms 12 Carcinoma, Non-Small-Cell Lung 10 Mouth Neoplasms 8 Laryngeal Neoplasms 8 Carcinoma 8 Small Cell Lung Carcinoma 7 Uterine Cervical Neoplasms 6 Urinary Bladder Neoplasms 6 Ovarian Neoplasms 6 Nasopharyngeal Carcinoma 6 Mesothelioma, Malignant 6 Hypopharyngeal Neoplasms 6 Pancreatic Neoplasms 5 Triple Negative Breast Neoplasms 4 Medulloblastoma 4 Ganglioneuroblastoma 4 Gallbladder Neoplasms 4 Breast Neoplasms 4 Stomach Neoplasms 3 Salivary Gland Neoplasms 3 Prostatic Neoplasms 3 Neuroblastoma 3 Lymphoid Interstitial Pneumonia 3 Fallopian Tube Neoplasms 3 Cholangiocarcinoma 3 Carcinoma, Transitional Cell 3 Adenocarcinoma of Lung 3 Testicular Neoplasms 2

Interventions

Temozolomide 101 Radiotherapy 49 Magnetic Resonance Spectroscopy 38 Radiation 28 Specimen Handling 25 pembrolizumab 22 Bevacizumab 22 Lomustine 16 Nivolumab 14 Surgical Procedures, Operative 10 atezolizumab 8 Cyclophosphamide 8 Biopsy 8 abemaciclib 7 Ipilimumab 7 fludarabine 6 Radiotherapy, Intensity-Modulated 6 Carboplatin 6 Aminolevulinic Acid 6 olaparib 5 Metformin 5 Drug Therapy 5 Diet, Ketogenic 5 Dianhydrogalactitol 5 poly ICLC 4 cemiplimab 4 Radiosurgery 4 Photons 4 Leukapheresis 4 Immunoglobulin G 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Glioblastoma × Platinum × 1 year × Clear all

NCT07138001 2025-08-22

Phase 2 Clinical Trial of KH617

Chengdu Kanghong Pharmaceutical Group Co., Ltd.

Phase 2 Not yet recruiting

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡